The Palico Private Equity Fund Marketplace
Remeditex Ventures is a private equity general partner firm headquartered in Dallas, TX, United States.
Navitor Pharmaceuticals, a biopharmaceutical company, secured $33m in Series B funding from Remeditex Ventures, Polaris Partners and others.
miRagen Therapeutics, a biopharmaceutical company developing innovative microRNA-based therapeutics, raised $41m in Series C funding.
Quartet Medicine, a biotechnology company, closed an additional $6.25m finalizing its Series A funding at a total of $23.25m.
Read more news concerning Remeditex Ventures
A sampling of Remeditex Ventures portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?